This year is the 40th edition of the International Symposium on Intensive Care and Emergency Medicine in Brussels and we are delighted to once again be exhibiting. Started in 1980, this meeting has become established as one of the largest in its field, now attracting more than 6200 participants from countries world-wide. You can hear Prof. Mebazaa’s talk on Dipeptidyl peptidase (DPP3) as a promising target as well as Prof. Laterre talking about Adrecizumab in patients with high adrenomedullin levels.
Meet us at booth: tba
Location: SQUARE Brussels Meeting Centre